27635790|t|miR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence
27635790|a|Cellular senescence has been implicated in diverse pathologies. However, there is conflicting evidence regarding the role of this process in tissue fibrosis. Although dysregulation of microRNAs is a key mechanism in the pathogenesis of lung fibrosis, it is unclear whether microRNAs function by regulating cellular senescence in the disease. In this study, we found that miR-34a demonstrated greater expression in the lungs of patients with idiopathic pulmonary fibrosis and in mice with experimental pulmonary fibrosis, with its primary localization in lung fibroblasts. More importantly, miR-34a was up-regulated significantly in both human and mouse lung myofibroblasts. We found that mice with miR-34a ablation developed more severe pulmonary fibrosis than did wild-type animals after fibrotic lung injury. Mechanistically, we found that miR-34a induced a senescent phenotype in lung fibroblasts because this microRNA increased senescence -associated β-galactosidase activity, enhanced expression of senescence markers, and decreased cell proliferative capacities. Consistently, we found that primary lung fibroblasts from fibrotic lungs of miR-34a - deficient mice had a diminished senescent phenotype and enhanced resistance to apoptosis as compared with those from wild-type animals. We also identified multiple miR-34a targets that likely mediated its activities in inducing senescence in lung fibroblasts. In conclusion, our data suggest that miR-34a functions through a negative feedback mechanism to restrain fibrotic response in the lungs by promoting senescence of pulmonary fibroblasts.
27635790	0	7	miR-34a	T114	C2351044
27635790	8	16	Inhibits	T052	C3463820
27635790	17	30	Lung Fibrosis	T047	C0034069
27635790	34	42	Inducing	T169	C0205263
27635790	43	47	Lung	T023	C0024109
27635790	48	69	Fibroblast Senescence	T043	C0007581
27635790	70	89	Cellular senescence	T043	C0007581
27635790	121	132	pathologies	T091	C0030664
27635790	164	172	evidence	T078	C3887511
27635790	200	207	process	T067	C1522240
27635790	211	226	tissue fibrosis	T046	C0016059
27635790	254	263	microRNAs	T114,T123	C1101610
27635790	273	282	mechanism	T169	C0441712
27635790	290	302	pathogenesis	T046	C0699748
27635790	306	319	lung fibrosis	T047	C0034069
27635790	343	352	microRNAs	T114,T123	C1101610
27635790	353	361	function	T169	C0542341
27635790	365	375	regulating	T038	C1327622
27635790	376	395	cellular senescence	T043	C0007581
27635790	403	410	disease	T047	C0012634
27635790	420	425	study	T062	C2603343
27635790	441	448	miR-34a	T114	C2351044
27635790	470	480	expression	T045	C0017262
27635790	488	493	lungs	T023	C0024109
27635790	497	505	patients	T101	C0030705
27635790	511	540	idiopathic pulmonary fibrosis	T047	C1800706
27635790	548	552	mice	T015	C0025929
27635790	571	589	pulmonary fibrosis	T047	C0034069
27635790	608	620	localization	T169	C0475264
27635790	624	628	lung	T023	C0024109
27635790	629	640	fibroblasts	T025	C0016030
27635790	660	667	miR-34a	T114	C2351044
27635790	672	684	up-regulated	T044	C0041904
27635790	707	712	human	T016	C0086418
27635790	717	722	mouse	T015	C0025929
27635790	723	727	lung	T023	C0024109
27635790	728	742	myofibroblasts	T025	C0225360
27635790	758	762	mice	T015	C0025929
27635790	768	775	miR-34a	T114	C2351044
27635790	776	784	ablation	T061	C0547070
27635790	807	825	pulmonary fibrosis	T047	C0034069
27635790	835	852	wild-type animals	T008	C0003062
27635790	859	867	fibrotic	T169	C0334129
27635790	868	879	lung injury	T037	C0273115
27635790	912	919	miR-34a	T114	C2351044
27635790	920	927	induced	T169	C0205263
27635790	930	939	senescent	T043	C2265405
27635790	940	949	phenotype	T032	C0031437
27635790	953	957	lung	T023	C0024109
27635790	958	969	fibroblasts	T025	C0016030
27635790	983	991	microRNA	T114,T123	C1101610
27635790	1002	1012	senescence	T043	C0007581
27635790	1025	1049	β-galactosidase activity	T044	C1150053
27635790	1060	1070	expression	T061	C0185117
27635790	1074	1084	senescence	T043	C0007581
27635790	1085	1092	markers	T201	C0005516
27635790	1108	1126	cell proliferative	T043	C0596290
27635790	1175	1179	lung	T023	C0024109
27635790	1180	1191	fibroblasts	T025	C0016030
27635790	1197	1205	fibrotic	T169	C0334129
27635790	1206	1211	lungs	T023	C0024109
27635790	1215	1222	miR-34a	T114	C2351044
27635790	1225	1234	deficient	T169	C0011155
27635790	1235	1239	mice	T015	C0025929
27635790	1246	1256	diminished	T081	C0205216
27635790	1257	1266	senescent	T043	C2265405
27635790	1267	1276	phenotype	T032	C0031437
27635790	1281	1289	enhanced	T052	C2349975
27635790	1290	1300	resistance	T169	C4281815
27635790	1304	1313	apoptosis	T043	C0162638
27635790	1342	1359	wild-type animals	T008	C0003062
27635790	1389	1396	miR-34a	T114	C2351044
27635790	1397	1404	targets	T169	C1521840
27635790	1430	1440	activities	T052	C0441655
27635790	1444	1452	inducing	T169	C0205263
27635790	1453	1463	senescence	T043	C0007581
27635790	1467	1471	lung	T023	C0024109
27635790	1472	1483	fibroblasts	T025	C0016030
27635790	1522	1529	miR-34a	T114	C2351044
27635790	1590	1598	fibrotic	T169	C0334129
27635790	1599	1607	response	T032	C0871261
27635790	1615	1620	lungs	T023	C0024109
27635790	1624	1633	promoting	T052	C0033414
27635790	1634	1644	senescence	T043	C0007581
27635790	1648	1657	pulmonary	T080	C2709248
27635790	1658	1669	fibroblasts	T025	C0016030